New Antibiotic Against Hospital-Acquired Superbug C. diff Shows Promise in Phase-One Clinical Trial

Medicine & Technology Dec 28, 2023

Omadacycline, a new antibiotic, shows promise in phase-one trial against hospital-acquired superbug C. diff. Continue reading to learn more details.

New Drug That Might Prevent Clostridioides Difficile Infections in Development [Study]

Mar 27, 2023

Scientists discovered a compound that could potentially prevent Clostridioides difficile infections. Read for more details.

FDA Approves Prescription Feces-Based Microbial Treatment for Life-Threatening Diarrhea

Dec 02, 2022

After many years, the US FDA finally approves the feces-based microbial treatment to be used in the prevention of recurring life-threatening diarrhea. Tap the article to learn more details.